Home Institutions Moffitt Cancer Center clinical trials Institution Directory
Clinical trials at Moffitt Cancer Center Sites in Tampa, FL
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
ClinicalTrials.gov public records Last synced Oct 17, 2026, 8:21 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
709
Current sort
Recently updated
Campus scope
Moffitt Cancer Center, Tampa, FL
Additional filters apply within this campus.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Showing 49–60 of 709 matching trials with a site at Moffitt Cancer Center, Tampa, FL.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.
Live official records
Conditions Recurrent Glioblastoma, IDH-Wildtype, Recurrent MGMT-Methylated Glioblastoma
Interventions Biospecimen Collection, Magnetic Resonance Imaging, Placebo Administration, Selinexor, Temozolomide Procedure · Drug
Lead sponsor National Cancer Institute (NCI) NIH
Eligibility 18 Years and older
Enrollment 97 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2023 – 2027
U.S. locations 36
States / cities Phoenix, Arizona • Duarte, California • La Jolla, California + 28 more
Conditions Myelodysplastic Syndrome, Acute Myeloid Leukemia
Interventions Azacitidine, Rezatapopt Drug
Lead sponsor M.D. Anderson Cancer Center Other
Eligibility 18 Years and older
Enrollment 24 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2029
U.S. locations 2
States / cities Tampa, Florida • Houston, Texas
Conditions Advanced Solid Tumor
Interventions BNT326, Pumitamig, Itraconazole, Paroxetine Drug
Lead sponsor BioNTech SE Industry
Eligibility 18 Years and older
Enrollment 1,438 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2030
U.S. locations 19
States / cities Phoenix, Arizona • San Francisco, California • Hartford, Connecticut + 15 more
Conditions Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Interventions Biospecimen Collection, Cemiplimab, Computed Tomography, Dexamethasone, Docetaxel, Magnetic Resonance Imaging, Ramucirumab Procedure · Biological · Drug
Lead sponsor SWOG Cancer Research Network Network
Eligibility 18 Years and older
Enrollment 378 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2028
U.S. locations 413
States / cities Daphne, Alabama • Fairhope, Alabama • Mobile, Alabama + 335 more
Conditions Ovarian Cancer, Endometrial Cancer, Germ Cell Tumor, Testicular Germ Cell Tumor, Ovarian Germ Cell Tumor
Interventions XmAb541 Biological
Lead sponsor Xencor, Inc. Industry
Eligibility 15 Years and older
Enrollment 282 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2028
U.S. locations 17
States / cities Duarte, California • Palo Alto, California • San Francisco, California + 14 more
Conditions Myelodysplastic Syndromes
Interventions Elritercept, Placebo Drug
Lead sponsor Takeda Industry
Eligibility 18 Years and older
Enrollment 225 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2032
U.S. locations 25
States / cities Duarte, California • Glendale, California • La Jolla, California + 21 more
Conditions Breast Neoplasms, Neoplasm Metastasis
Interventions LY4064809, Placebo, Ribociclib, Palbociclib, Abemaciclib, Anastrozole, Letrozole, Exemestane, Fulvestrant Drug
Lead sponsor Eli Lilly and Company Industry
Eligibility 18 Years and older
Enrollment 800 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2033
U.S. locations 129
States / cities Anchorage, Alaska • Chandler, Arizona • Phoenix, Arizona + 110 more
Conditions Oropharyngeal Carcinoma (OPC)
Interventions CRB-701, capcitabine, Cetuximab (EGFR inhibitor), Docetaxel Drug
Lead sponsor Corbus Pharmaceuticals Inc. Industry
Eligibility 18 Years and older
Enrollment 260 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2029
U.S. locations 38
States / cities Huntsville, Alabama • Tucson, Arizona • Duarte, California + 32 more
Conditions Metastatic Lung Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Adenocarcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Interventions Pembrolizumab, Pemetrexed, Carboplatin, Comprehensive Geriatric Assessment, Questionnaire Administration, Quality-of-Life Assessment Drug · Other
Lead sponsor Alliance for Clinical Trials in Oncology Other
Eligibility 70 Years and older
Enrollment 101 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2027
U.S. locations 505
States / cities Anchorage, Alaska • Fairbanks, Alaska • Kingman, Arizona + 318 more
Conditions Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8
Interventions Carboplatin, Computed Tomography, Magnetic Resonance Imaging, Nab-paclitaxel, Paclitaxel, Pembrolizumab, Pemetrexed, Positron Emission Tomography, Questionnaire Administration Drug · Procedure · Biological + 1 more
Lead sponsor National Cancer Institute (NCI) NIH
Eligibility 70 Years and older
Enrollment 304 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2039
U.S. locations 326
States / cities Fayetteville, Arkansas • Fort Smith, Arkansas • Rogers, Arkansas + 256 more
Conditions Relapsed or Refractory Large B-cell Lymphoma
Interventions KITE-753, Axicabtagene Ciloleucel, Fludarabine, Cyclophosphamide Drug
Lead sponsor Kite, A Gilead Company Industry
Eligibility 18 Years and older
Enrollment 550 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2031
U.S. locations 21
States / cities Goodyear, Arizona • Duarte, California • Stanford, California + 16 more
Conditions Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer
Interventions PF-08634404, Sigvotatug Vedotin, PF-08046054/SGN-PDL1V Biological
Lead sponsor Pfizer Industry
Eligibility 18 Years and older
Enrollment 162 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2033
U.S. locations 55
States / cities Fayetteville, Arkansas • Rogers, Arkansas • Springdale, Arkansas + 29 more About this Moffitt Cancer Center institution page
What this page lists ClinicalTrials.gov records that list Moffitt Cancer Center in Tampa, FL as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages , browse by condition , or browse by U.S. city .